Hikma Pharmaceuticals (HIK) Ordinary GBP 0.10

Sell:1,431.00pBuy:1,432.00pPrice increased16.00p (1.12%)

FTSE 250:Price decreased1.02%
Market closed |
Prices delayed by at least 15 minutes
Sell:1,431.00p
Buy:1,432.00p
Change:Price increased16.00p (1.12%)
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:1,431.00p
Buy:1,432.00p
Change:Price increased16.00p (1.12%)
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open1,402.00p
Previous close1,424.00p
Market cap£3.09bn
P/E ratio8.36
Volume1,239,935
Dividend yield4.29%
EMS500

Company information

Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and non-licensed pharmaceutical products. Its ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue228.98m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share£0.353
  • Ex-dividend date19 March 2026
  • Payment date30 April 2026

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.